# Optikira, LLC: Form D filings

Optikira, LLC, a pharmaceuticals company in Cleveland, OH, filed 6 Form D notices with the SEC between 2014 and 2019. The latest, on June 5, 2019, reports $2.7 million sold of a $5 million offering to 1 investor.

Find out what Optikira, LLC does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.

- [Watch for new raises](https://specstream.ai/workspace/ask?q=Tell%20me%20when%20Optikira%2C%20LLC%20files%20a%20new%20Form%20D%20or%20reports%20more%20money%20sold%2C%20with%20the%20filing&src=data-formd&kind=alert&entity=Optikira%2C%20LLC&page=%2Fdata%2Fform-d%2Fcompany%2Foptikira-llc-1627178)
- [Get founders and investors](https://specstream.ai/workspace/ask?q=For%20Optikira%2C%20LLC%2C%20find%20what%20the%20company%20does%2C%20its%20website%2C%20the%20founders%20and%20executives%20with%20their%20LinkedIn%20and%20work%20email%2C%20its%20investors%20and%20every%20funding%20round%20with%20the%20amounts%2C%20its%20headcount%20and%20any%20reported%20valuation&src=data-formd&kind=record&entity=Optikira%2C%20LLC&page=%2Fdata%2Fform-d%2Fcompany%2Foptikira-llc-1627178)

## The full lists

This record is a row of these lists. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, street, city, state, ZIP and 4 more), which open on your screen as soon as the payment clears and come by email.

- [Form D filings in Ohio](https://specstream.ai/data/form-d/state/ohio): 1,071 rows, by operating companies, filed since November 1, 2024, $53.55, or the new rows each week for $19 a month. Buy: https://specstream.ai/data/form-d/state/ohio
- [Form D filings in Pharmaceuticals](https://specstream.ai/data/form-d/industry/pharmaceuticals): 346 rows, by operating companies, filed since November 1, 2024, $17.30, or the new rows each week for $19 a month. Buy: https://specstream.ai/data/form-d/industry/pharmaceuticals

SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.

## Company details from the filing

- Address: 20600 CHAGRIN BLVD., SUITE 210, Cleveland, OH, 44122
- Phone: (216) 455-3216
- Industry: Pharmaceuticals
- Entity type: Limited Liability Company
- Incorporated in: Delaware
- Year incorporated: 2014
- Revenue range: Decline to Disclose
- Exemptions claimed: Rule 506(b)
- SEC identifier (CIK): 1627178

## Form D filings

| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
| --- | --- | --- | --- | --- | --- | --- | --- |
| Jun 5, 2019 | Amendment | $5,000,000 | $2,700,000 | $2,300,000 | 1 | May 25, 2018 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1627178/000162717819000001/0001627178-19-000001-index.htm) |
| Jul 31, 2018 | Amendment | $15,000,000 | $6,100,000 | $8,900,000 | 7 | Nov 30, 2014 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1627178/000162717818000002/0001627178-18-000002-index.htm) |
| Jun 7, 2018 | New notice | $5,000,000 | $1,100,000 | $3,900,000 | 1 | May 25, 2018 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1627178/000162717818000001/0001627178-18-000001-index.htm) |
| Aug 1, 2017 | Amendment | $15,000,000 | $5,300,000 | $9,700,000 | 7 | Nov 30, 2014 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1627178/000162717817000001/0001627178-17-000001-index.htm) |
| Aug 2, 2016 | Amendment | $8,000,000 | $3,700,000 | $4,300,000 | 6 | Nov 30, 2014 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1627178/000162717816000001/0001627178-16-000001-index.htm) |
| Dec 8, 2014 | New notice | $5,000,000 | $250,000 | $4,750,000 | 5 | Nov 30, 2014 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1627178/000162717814000001/0001627178-14-000001-index.htm) |

## Executive officers and directors named in the filing

| Name | Role | Note in the filing |
| --- | --- | --- |
| Mark Chin | Director |  |
| Bradley Backes | Director |  |
| Baiju Shah | Director |  |
| Theodore Torphy | Director |  |

## Other pharmaceuticals companies in Ohio that filed recently

- [EIKONOKLASTES THERAPEUTICS, INC.](https://specstream.ai/data/form-d/company/eikonoklastes-therapeutics-inc-1805698) $16.1 million · Oct 6, 2026

[Every Form D from the week of Jun 3, 2019](https://specstream.ai/data/form-d/week/2019-06-03) · [All recent filings in Ohio](https://specstream.ai/data/form-d/state/ohio) · [All recent Pharmaceuticals filings](https://specstream.ai/data/form-d/industry/pharmaceuticals)

Read from SEC EDGAR. Amount sold is what Optikira, LLC reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under [CC BY 4.0](https://creativecommons.org/licenses/by/4.0/).